Panel recommends at least 7 hours of sleep a night for most adults
the ONA take:
According to new recommendations from a panel led by a University of Washington sleep expert, adults needs at least 7 hours of sleep each night for best health.
The panel analyzed data from 5,300 scientific articles to determine the optimal amount of sleep each night for best health. The researchers found that people should be getting 7 hours of sleep, but 9 or more hours each night may be best for young adults, ill patients, and people recovering from sleep deficits.
Sleeping less than 7 hours each night is associated with depression, diabetes, heart disease, hypertension, and weight gain and obesity, as well as an increased risk for early death. Not enough sleep is also associated with decreased work performance, increased risk of accidents and errors, greater pain sensitivity, and reduced immune system function.
"Seven hours - that's the lower limit of the threshold," said Dr. Nathaniel F. Watson, a professor of neurology and co-director of the UW Medicine Sleep Center. "We don't want people walking away thinking, 'I need only seven hours of sleep a night.'"
Adults needs at least 7 hours of sleep each night for best health.
Sign Up for Free e-newsletters
- Managing Chemo Brain in Pediatric Survivors of Childhood Cancer
- Aggressive Therapy Provides No Additional Advantage in Metastatic Prostate Cancer
- Excretion of Volatile Organic Compounds Higher in AYAs Using Vaping Products
- FDA, ASHP Actions to Prevent or Manage Chemotherapy Drug Shortages
- Breast Cancer Screening Recommendations Not Completely Reflective of Race, Age
- Various Aspects of Palliative Care Focus Associated With Different Outcomes In Cancer
- Cost vs Benefits: The Controversy Over Proton Beam Radiotherapy
- Patient Expectations at Odds With Actual Outcomes for Radiotherapy in Breast Cancer
- Patients Desire More Online Tools and Access
- Metformin Plus Ruxolitinib: A Potential Therapeutic Alternative for Myeloproliferative Neoplasms
- Sexual Quality of Life Decreased During, After Chemotherapy for Digestive Cancers
- CHEMO-SUPPORT: A Nursing Intervention to Relieve Chemotherapy Symptom Burden
- Approach and Management of Checkpoint Inhibitor-related Immune Hepatitis
- Revised AJCC8 Demonstrates Superior Tumor Classification for HNCSCC
- Oral Androgen Receptor Inhibitor Granted FDA Approval for Nonmetastatic CRPC
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|